232 related articles for article (PubMed ID: 26148099)
21. Elevated suicide risk among patients with multiple sclerosis in Sweden.
Fredrikson S; Cheng Q; Jiang GX; Wasserman D
Neuroepidemiology; 2003; 22(2):146-52. PubMed ID: 12629281
[TBL] [Abstract][Full Text] [Related]
22. Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan.
Hader WJ
Can J Neurol Sci; 2010 Jan; 37(1):28-35. PubMed ID: 20169770
[TBL] [Abstract][Full Text] [Related]
23. The long-term impact of multiple sclerosis on the risk of divorce.
Landfeldt E; Castelo-Branco A; Svedbom A; Löfroth E; Kavaliunas A; Hillert J
Mult Scler Relat Disord; 2018 Aug; 24():145-150. PubMed ID: 30007180
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
25. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
Phadke JG
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
[TBL] [Abstract][Full Text] [Related]
26. Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012.
Burkill S; Montgomery S; Hajiebrahimi M; Hillert J; Olsson T; Bahmanyar S
Neurology; 2017 Aug; 89(6):555-562. PubMed ID: 28687718
[TBL] [Abstract][Full Text] [Related]
27. Survival and cause of death in multiple sclerosis: a prospective population-based study.
Hirst C; Swingler R; Compston DA; Ben-Shlomo Y; Robertson NP
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1016-21. PubMed ID: 18303108
[TBL] [Abstract][Full Text] [Related]
28. Mortality and cause of death in multiple sclerosis: findings from a prospective population-based cohort in Bizkaia, Basque Country, Spain.
Rodríguez-Antigüedad Zarranz A; Mendibe Bilbao M; Llarena González C; Audicana C
Neuroepidemiology; 2014; 42(4):219-25. PubMed ID: 24821604
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
[TBL] [Abstract][Full Text] [Related]
30. [Prognostics factors of renal failure in multiple sclerosis].
Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
[TBL] [Abstract][Full Text] [Related]
31. [Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients].
Sekkat Z; Ongagna JC; Collongues N; Fleury M; Blanc F; de Seze J;
Rev Neurol (Paris); 2012 Apr; 168(4):338-43. PubMed ID: 22341991
[TBL] [Abstract][Full Text] [Related]
32. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
[TBL] [Abstract][Full Text] [Related]
33. Survival of multiple sclerosis in Finland between 1964 and 1993.
Sumelahti ML; Tienari PJ; Wikström J; Salminen TM; Hakama M
Mult Scler; 2002 Aug; 8(4):350-5. PubMed ID: 12166507
[TBL] [Abstract][Full Text] [Related]
34. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
[TBL] [Abstract][Full Text] [Related]
35. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Papais-Alvarenga RM; Vasconcelos CC; Carra A; de Castillo IS; Florentin S; Diaz de Bedoya FH; Mandler R; de Siervi LC; Pimentel ML; Alvarenga MP; Alvarenga MP; Grzesiuk AK; Gama Pereira AB; Gomes Neto AP; Velasquez C; Soublette C; Fleitas CV; Diniz DS; Armas E; Batista E; Hernandez F; Pereira FF; Siqueira HH; Cabeça H; Sanchez J; Brooks JB; Gonçalves MV; Barroso MC; Ravelo ME; Castillo MC; Ferreira ML; Rocha MS; Parolin MK; Molina O; Marinho PB; Christo PP; Brant de Souza R; Pessanha Neto S; Camargo SM; Machado SC; Neri VC; Fragoso YD; Alvarenga H; Thuler LC
PLoS One; 2015; 10(7):e0127757. PubMed ID: 26222205
[TBL] [Abstract][Full Text] [Related]
36. The natural history of multiple sclerosis: a regional study with some longitudinal data.
Miller DH; Hornabrook RW; Purdie G
J Neurol Neurosurg Psychiatry; 1992 May; 55(5):341-6. PubMed ID: 1602305
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
El-Salem K; Khader Y
Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
[TBL] [Abstract][Full Text] [Related]
38. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
39. Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal.
Bergamaschi R; Montomoli C; Candeloro E; Fratti C; Citterio A; Cosi V
Neuroepidemiology; 2005; 25(1):15-8. PubMed ID: 15855800
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.
Riise T; Grønning M; Aarli JA; Nyland H; Larsen JP; Edland A
J Clin Epidemiol; 1988; 41(10):1031-6. PubMed ID: 3193137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
